Site icon OncologyTube

MYD88 mutation and management of Waldenstroms Macroglobulinemia

Morie A. Gertz, MD of Mayo Clinic discusses MYD88 mutation and management of Waldenstroms Macroglobulinemia at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

Exit mobile version